Patents by Inventor Yourang MA

Yourang MA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11873281
    Abstract: A conjugate of a potent cytotoxic agent with a cell-binding molecule having a structure represented by Formula (I), wherein T, L, m, n, , R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, and R13 are as defined herein, can be used for targeted treatment of cancer, autoimmune disease, and infectious disease.
    Type: Grant
    Filed: February 5, 2020
    Date of Patent: January 16, 2024
    Assignee: HANGZHOU DAC BIOTECH CO., LTD.
    Inventors: R. Yongxin Zhao, Yue Zhang, Yourang Ma
  • Patent number: 11834406
    Abstract: A conjugate of a potent cytotoxic agent with a cell-surface receptor binding molecule having a Formula (I), wherein T, L, m, n, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R1, R12, and R13 are defined herein, can be used for targeted treatment of cancer, autoimmune disease, and infectious disease.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: December 5, 2023
    Assignee: HANGZHOU DAC BIOTECH CO., LTD.
    Inventors: R. Yongxin Zhao, Yue Zhang, Yourang Ma
  • Patent number: 11767294
    Abstract: A conjugate of a potent cytotoxic agent with a cell-surface receptor binding molecule having a Formula (I), wherein T, L, m, n, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, and R13 are defined herein, can be used for targeted treatment of cancer, autoimmune disease, and infectious disease.
    Type: Grant
    Filed: May 9, 2019
    Date of Patent: September 26, 2023
    Assignee: HANGZHOU DAC BIOTECH CO., LTD.
    Inventors: R. Yongxin Zhao, Yue Zhang, Yourang Ma
  • Publication number: 20200172480
    Abstract: A conjugate of a potent cytotoxic agent with a cell-binding molecule having a structure represented by Formula (I), wherein T, L, m, n, , R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, and R13 are as defined herein, can be used for targeted treatment of cancer, autoimmune disease, and infectious disease.
    Type: Application
    Filed: February 5, 2020
    Publication date: June 4, 2020
    Applicant: HANGZHOU DAC BIOTECH CO., LTD.
    Inventors: R. Yongxin ZHAO, Yue ZHANG, Yourang MA
  • Patent number: 10501412
    Abstract: A conjugate of a potent cytotoxic agent with a cell-surface receptor binding molecule having a formula (I), wherein T, L, m, n, Y, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R12, and R13 are defined herein, can be used for targeted treatment of cancer, autoimmune disease, and infectious disease.
    Type: Grant
    Filed: July 12, 2012
    Date of Patent: December 10, 2019
    Assignee: HANGZHOU DAC BIOTECH CO., LTD.
    Inventors: R. Yongxin Zhao, Yue Zhang, Yourang Ma
  • Publication number: 20190367453
    Abstract: A conjugate of a potent cytotoxic agent with a cell-surface receptor binding molecule having a Formula (I), wherein T, L, m, n, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R1, R12, and R13 are defined herein, can be used for targeted treatment of cancer, autoimmune disease, and infectious disease.
    Type: Application
    Filed: August 13, 2019
    Publication date: December 5, 2019
    Applicant: HANGZHOU DAC BIOTECH CO., LTD.
    Inventors: R. Yongxin ZHAO, Yue ZHANG, Yourang MA
  • Publication number: 20190330149
    Abstract: A conjugate of a potent cytotoxic agent with a cell-surface receptor binding molecule having a Formula (I), wherein T, L, m, n, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, and R13 are defined herein, can be used for targeted treatment of cancer, autoimmune disease, and infectious disease.
    Type: Application
    Filed: May 9, 2019
    Publication date: October 31, 2019
    Applicant: HANGZHOU DAC BIOTECH CO., LTD.
    Inventors: R. Yongxin ZHAO, Yue ZHANG, Yourang MA
  • Patent number: 10399941
    Abstract: A conjugate of a potent cytotoxic agent with a cell-surface receptor binding molecule having a Formula (I), wherein T, L, m, n, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, and R13 are defined herein, can be used for targeted treatment of cancer, autoimmune disease, and infectious disease.
    Type: Grant
    Filed: April 16, 2014
    Date of Patent: September 3, 2019
    Assignee: HANGZHOU DAC BIOTECH CO., LTD.
    Inventors: R. Yongxin Zhao, Yue Zhang, Yourang Ma
  • Publication number: 20180021448
    Abstract: A conjugate of a potent cytotoxic agent with a cell-surface receptor binding molecule having a Formula (I), wherein T, L, m, n, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, and R13 are defined herein, can be used for targeted treatment of cancer, autoimmune disease, and infectious disease.
    Type: Application
    Filed: April 16, 2014
    Publication date: January 25, 2018
    Applicant: Hangzhou DAC Biotech Co., Ltd.
    Inventors: R. Yongxin Zhao, Yue Zhang, Yourang Ma
  • Publication number: 20170296663
    Abstract: A conjugate of a potent cytotoxic agent with a cell-surface receptor binding molecule having a Formula (I), wherein T, L, m, n, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, and R13 are defined herein, can be used for targeted treatment of cancer, autoimmune disease, and infectious disease.
    Type: Application
    Filed: April 16, 2014
    Publication date: October 19, 2017
    Applicant: Hangzhou DAC Biotech Co., Ltd.
    Inventors: R. Yongxin Zhao, Yue Zhang, Yourang Ma
  • Publication number: 20170157262
    Abstract: A conjugate of a potent cytotoxic agent with a cell-surface receptor binding molecule having a formula (I), wherein T, L, m, n, Y, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R12, and R13 are defined herein, can be used for targeted treatment of cancer, autoimmune disease, and infectious disease.
    Type: Application
    Filed: July 12, 2012
    Publication date: June 8, 2017
    Inventors: R. Yongxin ZHAO, Yue ZHANG, Yourang MA